503b tirzepatide Compounded With B6 (Pyridoxine) UPDATE [March 7, 2025]: OFA

After 52 weeks of treatment, the proportion of participants in the oral semaglutide group achieving an A1C of less than 7.0% was 58.3% (treatment-policy estimand) and 62.8% (trial-product estimand), compared with 25.2% (treatment-policy estimand) and 28.3% (trial-product estimand) for the group receiving 100 mg of sitagliptin daily

In some cases, individuals may also experience facial pain or discomfort that can extend to the neck and shoulders, further complicating the diagnosis and treatment

More serious but rare side effects include: Pancreatitis (inflammation of the pancreas) Gallbladder problems Changes in heart rate While these serious complications are uncommon, they underscore why these drugs require medical supervision

Its possible for heavy computer usage and typing to increase your risk for CTS, but its never been proven to be a direct cause